News and views

Renal denervation (RDN) revisited

A novel, catheter-based technique is looking promising for the treatment of refractory hypertension. Renal sympathetic hyperactivity is associated with the development of...

The National Institute for Health and Clinical Excellence (NICE) has published a new guidance on prevention of cardiovascular disease at the population level....

A trial testing testosterone gel in older men with mobility limitations has been stopped early because of an increased risk of cardiovascular events in the...

A study of a new drug for atrial fibrillation, apixaban (Pfizer/Bristol-Myers Squibb), has been stopped early because of...

Another trial stopped early because of benefit is EMPHASIS-HF (Eplerenone in Mild Patients Hospitalisation And SurvIval Study in Heart Failure) which looked at the aldosterone...

A new study suggests that patients with metabolic syndrome are no more at risk of future myocardial infarction (MI) than those with diabetes or hypertension...

The influence and importance of valve disease is increasing and yet the subject remains under-represented. There is, for example, no group affiliated to the British...

Patients at moderate to high risk of cardiovascular disease should be screened for elevated Lp(a) and take niacin to lower levels to under 50 mg/dL...

A new study has confirmed that there has been a significant drop in hospital admissions for myocardial infarction (MI) after the introduction of smoke-free legislation...